Serveur d'exploration H2N2

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Influenza: prospect for prevention and control.

Identifieur interne : 000128 ( 1968/Analysis ); précédent : 000127; suivant : 000129

Influenza: prospect for prevention and control.

Auteurs : Jason R. Williams [États-Unis] ; Po-Yen Chen ; Cheng T. Cho ; Tom D Y. Chin

Source :

RBID : pubmed:12515400

Descripteurs français

English descriptors

Abstract

Influenza is an emerging and re-emerging disease. Since the late 1930s influenza viruses have been isolated yearly from different parts of the world during epidemics and pandemics. The "epidemiologic success" of influenza is due largely to rapid and unpredictable antigenic changes (antigenic drift) among human influenza viruses, and the emergence of new subtypes (antigenic shift), mostly from reassortment between human and avian influenza viruses. Antigenic shifts were attributed to the global pandemic viruses of 1957 (H2N2 Asian flu) and 1968 (H3N2 Hong Kong flu). Concern over possible new pandemics has been heightened by recent reports of human infection in Asia in 1997 with avian viruses (H5N1) and in 1999 (H9N2) and isolation of human-avian reassorted viruses from pigs and humans in Europe. Influenza has a high rate of inapparent infection, short incubation and high infectivity; epidemics usually start abruptly and spread rapidly to neighboring communities and countries. Isolation and quarantine are often unsuccessful in preventing the spread of the infection. Although not perfect, immunization and chemoprophylaxis are highly effective at minimizing the spread of influenza and reducing morbidity and mortality, social disruption and economic loss. Plans for future influenza epidemics and pandemics require national and international programs to be in place for the monitoring of influenza activity, the dissemination and exchange of information and the provision and delivery of sufficient quantities of vaccines and antiviral agents. This paper reviews and discusses the antigenic variations of the influenza virus, potential influenza pandemics, protective efficacy of inactivated vaccines and antiviral agents and preparation for control of future epidemics and pandemics.

PubMed: 12515400


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:12515400

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Influenza: prospect for prevention and control.</title>
<author>
<name sortKey="Williams, Jason R" sort="Williams, Jason R" uniqKey="Williams J" first="Jason R" last="Williams">Jason R. Williams</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Pediatrics, University of Kansas School of Medicine, Kansas City, Kansas 66160, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Pediatrics, University of Kansas School of Medicine, Kansas City, Kansas 66160</wicri:regionArea>
<wicri:noRegion>Kansas 66160</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Chen, Po Yen" sort="Chen, Po Yen" uniqKey="Chen P" first="Po-Yen" last="Chen">Po-Yen Chen</name>
</author>
<author>
<name sortKey="Cho, Cheng T" sort="Cho, Cheng T" uniqKey="Cho C" first="Cheng T" last="Cho">Cheng T. Cho</name>
</author>
<author>
<name sortKey="Chin, Tom D Y" sort="Chin, Tom D Y" uniqKey="Chin T" first="Tom D Y" last="Chin">Tom D Y. Chin</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2002">2002</date>
<idno type="RBID">pubmed:12515400</idno>
<idno type="pmid">12515400</idno>
<idno type="wicri:Area/PubMed/Corpus">000341</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000341</idno>
<idno type="wicri:Area/PubMed/Curation">000341</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000341</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000316</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000316</idno>
<idno type="wicri:Area/Ncbi/Merge">000069</idno>
<idno type="wicri:Area/Ncbi/Curation">000069</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000069</idno>
<idno type="wicri:doubleKey">1607-551X:2002:Williams J:influenza:prospect:for</idno>
<idno type="wicri:Area/Main/Merge">001781</idno>
<idno type="wicri:Area/Main/Curation">001745</idno>
<idno type="wicri:Area/Main/Exploration">001745</idno>
<idno type="wicri:Area/1968/Extraction">000128</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Influenza: prospect for prevention and control.</title>
<author>
<name sortKey="Williams, Jason R" sort="Williams, Jason R" uniqKey="Williams J" first="Jason R" last="Williams">Jason R. Williams</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Pediatrics, University of Kansas School of Medicine, Kansas City, Kansas 66160, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Pediatrics, University of Kansas School of Medicine, Kansas City, Kansas 66160</wicri:regionArea>
<wicri:noRegion>Kansas 66160</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Chen, Po Yen" sort="Chen, Po Yen" uniqKey="Chen P" first="Po-Yen" last="Chen">Po-Yen Chen</name>
</author>
<author>
<name sortKey="Cho, Cheng T" sort="Cho, Cheng T" uniqKey="Cho C" first="Cheng T" last="Cho">Cheng T. Cho</name>
</author>
<author>
<name sortKey="Chin, Tom D Y" sort="Chin, Tom D Y" uniqKey="Chin T" first="Tom D Y" last="Chin">Tom D Y. Chin</name>
</author>
</analytic>
<series>
<title level="j">The Kaohsiung journal of medical sciences</title>
<idno type="ISSN">1607-551X</idno>
<imprint>
<date when="2002" type="published">2002</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Antiviral Agents (therapeutic use)</term>
<term>Disease Outbreaks</term>
<term>Humans</term>
<term>Influenza A virus (isolation & purification)</term>
<term>Influenza Vaccines (immunology)</term>
<term>Influenza, Human (epidemiology)</term>
<term>Influenza, Human (prevention & control)</term>
<term>Influenza, Human (virology)</term>
<term>Vaccines, DNA (immunology)</term>
<term>Vaccines, Inactivated (immunology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Antiviraux (usage thérapeutique)</term>
<term>Flambées de maladies</term>
<term>Grippe humaine ()</term>
<term>Grippe humaine (virologie)</term>
<term>Grippe humaine (épidémiologie)</term>
<term>Humains</term>
<term>Vaccins antigrippaux (immunologie)</term>
<term>Vaccins inactivés (immunologie)</term>
<term>Vaccins à ADN (immunologie)</term>
<term>Virus de la grippe A (isolement et purification)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en">
<term>Influenza Vaccines</term>
<term>Vaccines, DNA</term>
<term>Vaccines, Inactivated</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Antiviral Agents</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr">
<term>Vaccins antigrippaux</term>
<term>Vaccins inactivés</term>
<term>Vaccins à ADN</term>
</keywords>
<keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en">
<term>Influenza A virus</term>
</keywords>
<keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr">
<term>Virus de la grippe A</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en">
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr">
<term>Antiviraux</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr">
<term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en">
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr">
<term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Disease Outbreaks</term>
<term>Humans</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Flambées de maladies</term>
<term>Grippe humaine</term>
<term>Humains</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Influenza is an emerging and re-emerging disease. Since the late 1930s influenza viruses have been isolated yearly from different parts of the world during epidemics and pandemics. The "epidemiologic success" of influenza is due largely to rapid and unpredictable antigenic changes (antigenic drift) among human influenza viruses, and the emergence of new subtypes (antigenic shift), mostly from reassortment between human and avian influenza viruses. Antigenic shifts were attributed to the global pandemic viruses of 1957 (H2N2 Asian flu) and 1968 (H3N2 Hong Kong flu). Concern over possible new pandemics has been heightened by recent reports of human infection in Asia in 1997 with avian viruses (H5N1) and in 1999 (H9N2) and isolation of human-avian reassorted viruses from pigs and humans in Europe. Influenza has a high rate of inapparent infection, short incubation and high infectivity; epidemics usually start abruptly and spread rapidly to neighboring communities and countries. Isolation and quarantine are often unsuccessful in preventing the spread of the infection. Although not perfect, immunization and chemoprophylaxis are highly effective at minimizing the spread of influenza and reducing morbidity and mortality, social disruption and economic loss. Plans for future influenza epidemics and pandemics require national and international programs to be in place for the monitoring of influenza activity, the dissemination and exchange of information and the provision and delivery of sufficient quantities of vaccines and antiviral agents. This paper reviews and discusses the antigenic variations of the influenza virus, potential influenza pandemics, protective efficacy of inactivated vaccines and antiviral agents and preparation for control of future epidemics and pandemics.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Chen, Po Yen" sort="Chen, Po Yen" uniqKey="Chen P" first="Po-Yen" last="Chen">Po-Yen Chen</name>
<name sortKey="Chin, Tom D Y" sort="Chin, Tom D Y" uniqKey="Chin T" first="Tom D Y" last="Chin">Tom D Y. Chin</name>
<name sortKey="Cho, Cheng T" sort="Cho, Cheng T" uniqKey="Cho C" first="Cheng T" last="Cho">Cheng T. Cho</name>
</noCountry>
<country name="États-Unis">
<noRegion>
<name sortKey="Williams, Jason R" sort="Williams, Jason R" uniqKey="Williams J" first="Jason R" last="Williams">Jason R. Williams</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/1968/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000128 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/1968/Analysis/biblio.hfd -nk 000128 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    1968
   |étape=   Analysis
   |type=    RBID
   |clé=     pubmed:12515400
   |texte=   Influenza: prospect for prevention and control.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/1968/Analysis/RBID.i   -Sk "pubmed:12515400" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/1968/Analysis/biblio.hfd   \
       | NlmPubMed2Wicri -a H2N2V1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021